IFNα induces CCR5 in CD4+ T cells of HIV patients causing pathogenic elevation
Abstract Background Among people living with HIV, elite controllers (ECs) maintain an undetectable viral load, even without receiving anti-HIV therapy. In non-EC patients, this therapy leads to marked improvement, including in immune parameters, but unlike ECs, non-EC patients still require ongoing...
Main Authors: | Hélène Le Buanec, Valérie Schiavon, Marine Merandet, Alexandre How-Kit, Hongshuo Song, David Bergerat, Céline Fombellida-Lopez, Armand Bensussan, Jean-David Bouaziz, Arsène Burny, Gilles Darcis, Mohammad M. Sajadi, Shyamasundaran Kottilil, Daniel Zagury, Robert C. Gallo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-03-01
|
Series: | Communications Medicine |
Online Access: | https://doi.org/10.1038/s43856-024-00453-7 |
Similar Items
-
Early elevated IFNα is a key mediator of HIV pathogenesis
by: Hélène Le Buanec, et al.
Published: (2024-03-01) -
Neutralizing anti-Tat antibodies prolonged HAART interruption in vaccines in a prospective structured interruption study
by: Redfield Robert, et al.
Published: (2006-12-01) -
Immunomodulatory therapies for COVID-19
by: Poonam Mathur, et al.
Published: (2022-08-01) -
IFN-alpha-induced upregulation of CCR5 leads to expanded HIV tropism in vivo.
by: Cheryl A Stoddart, et al.
Published: (2010-02-01) -
Use of oral polio vaccine and the incidence of COVID-19 in the world.
by: Farrokh Habibzadeh, et al.
Published: (2022-01-01)